Topical Hyaluronic Acid vs. Standard of Care for the Prevention of Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer: Single-Blind Randomized Phase III Clinical Trial

Chelsea Pinnix; George H. Perkins; Eric A. Strom; Welela Tereffe; Wendy Woodward; Julia L. Oh; Lisa Arriaga; Mark F. Munsell; Patrick Kelly; Karen E. Hoffman; Benjamin D. Smith; Thomas A. Buchholz; T. Kuan Yu

doi:10.1016/j.ijrobp.2011.09.021

Topical Hyaluronic Acid vs. Standard of Care for the Prevention of Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer: Single-Blind Randomized Phase III Clinical Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.09.021 ◽

2012 ◽

Vol 83 (4) ◽

pp. 1089-1094 ◽

Cited By ~ 35

Author(s):

Chelsea Pinnix ◽

George H. Perkins ◽

Eric A. Strom ◽

Welela Tereffe ◽

Wendy Woodward ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Hyaluronic Acid ◽

Adjuvant Radiotherapy ◽

Standard Of Care ◽

Phase Iii ◽

Radiation Dermatitis ◽

Phase Iii Clinical Trial ◽

Single Blind

Download Full-text

Topical Hyaluronic Acid vs. Standard of Care for the Prevention of Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer: Single-Blind Randomized Phase III Clinical Trial

Breast Diseases A Year Book Quarterly ◽

10.1016/j.breastdis.2013.04.021 ◽

2013 ◽

Vol 24 (2) ◽

pp. 181-182

Author(s):

K.C. Horst ◽

J. Lapole

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Hyaluronic Acid ◽

Adjuvant Radiotherapy ◽

Standard Of Care ◽

Phase Iii ◽

Radiation Dermatitis ◽

Phase Iii Clinical Trial ◽

Single Blind

Download Full-text

Randomized Phase III Clinical Trial to Compare Topical Hyaluronic Acid-based and Petrolatum-based Gels for Radiation Dermatitis in Breast Cancer Patients

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.07.056 ◽

2010 ◽

Vol 78 (3) ◽

pp. S6

Author(s):

C.C. Pinnix ◽

L. Arriaga ◽

M.F. Munsell ◽

G.H. Perkins ◽

E.A. Strom ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Hyaluronic Acid ◽

Cancer Patients ◽

Phase Iii ◽

Radiation Dermatitis ◽

Breast Cancer Patients ◽

Phase Iii Clinical Trial

Download Full-text

Abstract OT3-01-03: Phase III clinical trial to evaluate patient's preference for subcutaneous (SC) versus intravenous (IV) trastuzumab administration in patients with HER2 positive, advanced breast cancer (ABC) under IV trastuzumab treatment for at least 4 months and without disease progression. ChangHER-SC study (GEICAM/2012-07)

10.1158/1538-7445.sabcs15-ot3-01-03 ◽

2016 ◽

Author(s):

E Ciruelos ◽

E González ◽

A Lluch ◽

L Garrigós ◽

V Quiroga ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Advanced Breast Cancer ◽

Disease Progression ◽

Advanced Breast ◽

Phase Iii ◽

Her2 Positive ◽

Phase Iii Clinical Trial ◽

Trastuzumab Treatment

Download Full-text

Abstract PD6-07: Clinical significance of CD73 expression in triple-negative breast cancer from the BIG 02-98 adjuvant phase III clinical trial

10.1158/1538-7445.sabcs17-pd6-07 ◽

2018 ◽

Author(s):

L Buisseret ◽

S Pommey ◽

B Allard ◽

S Garaud ◽

MA Bergeron ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Clinical Significance ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Phase Iii ◽

Phase Iii Clinical Trial ◽

Cd73 Expression

Download Full-text

Analytical validation of Bond Oracle HER2 IHC system for identifying low to intermediate HER2-expressing breast cancer in NeuVax PRESENT phase III clinical trial.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e11609 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e11609-e11609

Author(s):

Amit K Jain ◽

Sonia Kumar ◽

Gavin S. Choy ◽

Desiree Hollemon ◽

Elizabeth Ann Mittendorf

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Phase Iii ◽

Analytical Validation ◽

Phase Iii Clinical Trial

Download Full-text

Macrocycle Therapeutics to Treat Life-threatening Diseases

CHIMIA International Journal for Chemistry ◽

10.2533/chimia.2021.508 ◽

2021 ◽

Vol 75 (6) ◽

pp. 508-513

Author(s):

Gokhan Batur ◽

Philipp Ermert ◽

Johann Zimmermann ◽

Daniel Obrecht

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Membrane Proteins ◽

Outer Membrane ◽

Outer Membrane Proteins ◽

Phase Iii ◽

Phase Iii Clinical Trial ◽

Life Threatening ◽

Novel Antibiotics

Polyphor's macrocycle platform led to the discovery of novel antibiotics addressing specifically Gramnegative bacteria by targeting outer membrane proteins. Furthermore, POL6014, an inhibitor of neutrophile elastase and balixafortide, a CXCR4 inhibitor have been discovered and developed from the platform. Currently a combination of balixafortide and eribulin is in Phase III clinical trial for the treatment of patients with advanced metastatic HER2-negative breast cancer.

Download Full-text

Abstract P3-12-07: A multicenter randomized double-blind phase III clinical trial to evaluate the efficacy and safety of GCPGC, a novel pegylated G-CSF in patients receiving DA or TAC chemotherapy for breast cancer compared to peg-filgrastim

10.1158/1538-7445.sabcs14-p3-12-07 ◽

2015 ◽

Author(s):

Joo Han Lim ◽

Ki-Hyeong Lee ◽

Keon-Uk Park ◽

In-Hae Park ◽

Eun Kyung Cho ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Tac Chemotherapy

Download Full-text

Abstract P3-07-42: Predicting outcome and benefit to first-line bevacizumab in advanced/metastatic hormone receptor (HR)+/HER2-negative breast cancer (BC) treated with endocrine therapy: A correlative science study from the LEA phase III clinical trial (GEICAM/2006-11_GBG 051)

10.1158/1538-7445.sabcs15-p3-07-42 ◽

2016 ◽

Author(s):

A Prat ◽

J de la Haba-Rodriguez ◽

Á Guerrero ◽

JA García-Sáenz ◽

S Morales ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Phase Iii ◽

First Line ◽

Science Study ◽

Phase Iii Clinical Trial ◽

Predicting Outcome

Download Full-text

Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer

Health and Quality of Life Outcomes ◽

10.1186/s12955-016-0449-z ◽

2016 ◽

Vol 14 (1) ◽

Cited By ~ 15

Author(s):

Emily Nash Smyth ◽

Wei Shen ◽

Lee Bowman ◽

Patrick Peterson ◽

William John ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Clinical Trial ◽

Prognostic Factors ◽

Advanced Breast Cancer ◽

Phase Iii ◽

Life Domains ◽

Phase Iii Clinical Trial ◽

Patient Reported

Download Full-text

The efficacy and safety of neoadjuvant chemotherapy +/− letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial

Breast Cancer Research and Treatment ◽

10.1007/s10549-011-1814-6 ◽

2011 ◽

Vol 132 (3) ◽

pp. 853-861 ◽

Cited By ~ 16

Author(s):

Mohammad Mohammadianpanah ◽

Yaghoub Ashouri ◽

Sare Hoseini ◽

Niloofar Amadloo ◽

Abdolrasoul Talei ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Clinical Trial

Download Full-text